000 01001 a2200289 4500
005 20250514213346.0
264 0 _c20050706
008 200507s 0 0 eng d
022 _a0012-186X
024 7 _a10.1007/s00125-004-1616-z
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFerrannini, E
245 0 0 _aRosiglitazone and lipid metabolism.
_h[electronic resource]
260 _bDiabetologia
_cJan 2005
300 _a6-7 p.
_bdigital
500 _aPublication Type: Journal Article; Comment
650 0 4 _aAdipose Tissue
_xmetabolism
650 0 4 _aDiabetes Mellitus
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xpharmacology
650 0 4 _aLipid Metabolism
650 0 4 _aPeroxisome Proliferator-Activated Receptors
_xphysiology
650 0 4 _aRosiglitazone
650 0 4 _aThiazolidinediones
_xpharmacology
773 0 _tDiabetologia
_gvol. 48
_gno. 1
_gp. 6-7
856 4 0 _uhttps://doi.org/10.1007/s00125-004-1616-z
_zAvailable from publisher's website
999 _c15304778
_d15304778